Migraine is a neurovascular disorder that affects over 1 billion people worldwide. Its
widespread prevalence, and associated disability, have a range of negative and substantial …

Migraine is a highly disabling neurological disorder that directly affects more than 1 billion
individuals worldwide. Available treatment options differ between countries and include …

Migraine is a common, chronic, disorder that is typically characterized by recurrent disabling
attacks of headache and accompanying symptoms, including aura. The aetiology is …

Combination drugs are an important class of US FDA approved pharmaceuticals. These
drugs have been on a continuous growth trajectory since the first combination drugs were …

White biotechnology, or industrial biotechnology, is drawing much attention as a solution to
produce energy, chemicals and other materials from renewable resources. White …

Migraine — Current Understanding and Treatment | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …

Migraine is a common and disabling primary headache disorder with a significant
socioeconomic burden. The management of migraine is multifaceted and is generally …

Background: Migraine is one of the most frequent disabling neurological conditions with a
major impact on the patients' quality of life. Objectives: To give evidence‐based or expert …

Background In an effort to improve migraine management around the world, the
International Headache Society (IHS) has here developed a list of practical …

Background The triptans, selective serotonin 5-HT 1B/1D agonists, are very effective acute
migraine drugs with a well-developed scientific rationale. Seven different triptans will soon …